# Minimally Invasive Imagery With Indocyanine Green

> **NCT02621268** · PHASE1 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 48 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** Indocyanine Green

## Key facts

- **NCT ID:** NCT02621268
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2018-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02621268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02621268, "Minimally Invasive Imagery With Indocyanine Green". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02621268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*